Cargando…
Indeterminate Colitis – Update on Treatment Options
Indeterminate colitis (IC) is described in approximately 5–15% of patients with inflammatory bowel disease (IBD). It usually reflects a difficulty or lack of clarity in distinguishing between ulcerative colitis (UC) and Crohn’s disease (CD) on biopsy or colectomy specimens. The diagnostic difficulty...
Autores principales: | Venkateswaran, Niranjani, Weismiller, Scott, Clarke, Kofi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643196/ https://www.ncbi.nlm.nih.gov/pubmed/34876831 http://dx.doi.org/10.2147/JIR.S268262 |
Ejemplares similares
-
An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
por: Ferretti, Francesca, et al.
Publicado: (2022) -
Improving outpatient care in adult inflammatory bowel disease: effect of implementation of a reminder checklist in the electronic health records (IBD-ERS)—a pilot study
por: Bernasko, Nana, et al.
Publicado: (2023) -
Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
por: Senguttuvan, Nagendra Boopathy, et al.
Publicado: (2021) -
Ubiquitous Colonic Ileal Metaplasia Consistent with the Diagnosis of Crohn’s Colitis among Indeterminate Colitis Cohorts
por: Breaux, William A., et al.
Publicado: (2023) -
The indeterminate adrenal lesion
por: Sahdev, Anju, et al.
Publicado: (2010)